Docking Studies of Natural Product Derived Carvacrol Type Aromatic Monoterpenes Against COVID-19 and Comparison with Used Synthetic Drugs: Potential of Carvacryl Acetate Against SARS-CoV-2 (COVID-19)
Author:
ÖZHAN KOCAKAYA Şafak1ORCID, ERTAŞ Abdulselam1ORCID, YENER İsmail1ORCID, ARICA Enes2ORCID, DİNCEL Demet3ORCID
Affiliation:
1. DICLE UNIVERSITY 2. DİCLE ÜNİVERSİTESİ, TIP FAKÜLTESİ 3. BEZM-İ ÂLEM VAKIF ÜNİVERSİTESİ
Abstract
The COVID-19 pandemic that broken out in 2020 is becoming more worrying for the world. Although there is no 100 % success against COVID-19, certain synthetic drugs are currently used despite various side effects. Therefore, studies on the discovery of new treatment alternatives come to the fore. Studies so far show that natural products are still important resources for the discovery of new therapeutic agents. Plant-derived essential oils are complex volatiles composed of various phytochemicals, mostly containing compounds such as sesquiterpenes, monoterpenes, and phenylpropanoids. In this study, especially thymol and carvacrol compounds specific to the Lamiaceae (Labiate) family and aromatic monoterpenes derived from these compounds were modeled against COVID-19. Results were compared with remdesivir, hydroxychloroquine, and favipiravir used as synthetic drugs. Dock and molecular dynamics simulations analyzed these molecules’ potential inhibitor efficiency of the SARS-CoV2 Mpro. Lipinski parameters and Docking results were demonstrated that ligands carvacrol (2), carvacryl acetate (11) and cuminaldehyde (12) are potential inhibitors towards COVID-19. According to the results, it is seen that medicinal aromatic herbs, which contain these volatile components with the fewer side effects than synthetic drugs, have the potential to be used as supplements in the pharmaceutical industry.
Publisher
Dicle University
Reference46 articles.
1. TCSB. Republic of Turkey Ministry of Health, general directorate of public health, COVID-19 (SARS-CoV-2 infection) general ınformation, epidemiology and diagnosis, scientific advisory board work: Ankara, Turkey, 2020. 2. P. Zhou, X. L. Yang, X. G. Wang, B. Hu, L. Zhang, W. Zhang, H. R. Si, Y. Zhu, B. Li, C. L. Huang, H. D. Chen, J. Chen, Y. Luo, H. Guo, R. D. Jiang, M. Q. Liu, Y. Chen, X. R. Shen, X. Wang, X. S. Zheng, K. Zhao, Q. J. Chen, F. Deng, L. L. Liu, B. Yan, F. X. Zhan, Y. Y. Wang, G. F. Xiao and Z. L. Shi, ‘‘A Pneumonia outbreak associated with a new coronavirus of probable bat origin,’’ Nature, vol. 579, pp. 270–273, 2020, doi: 10.1038/s41586-020-2012-7 3. M. Akdeniz, A. Ertas, I. Yener, M. Fırat and U. Kolak, ‘‘Phytochemical and biological investigations on two Nepeta species: Nepeta heliotropifolia and N. congesta subsp. cryptantha,’’ J. Food Biochem., Vol. 44, Article ID. e13124, 2020, doi: 10.1111/jfbc.13124 4. D. Bakir, M. Akdeniz, A. Ertas, M. A. Yilmaz, I. Yener, M. Firat and U. Kolak, ‘‘A GC–MS method validation for quantitative investigation of some chemical markers in Salvia hypargeia Fisch. & C.A. Mey. of Turkey: Enzyme inhibitory potential of ferruginol,’’ J. Food Biochem., Vol. 44, Article ID. 13350, 2020, doi: 10.1111/jfbc.13350 5. S. Kocakaya-Ozhan, A Ertas, I Yener, B. Ercan, E. Varhan-Oral, M. Akdeniz, E. Kaplaner, G. Topcu and U. Kolak, ‘‘Selective in-vitro enzymes' inhibitory activities of fingerprints compounds of Salvia species and molecular docking simulations,’’ Iranian Journal of Pharmaceutical Research, vol. 19, pp. 187-198, 2020, doi: 10.22037/ijpr.2020.112498.13801
|
|